<p>The Covid-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.</p>.<p>The encouraging results, based on an analysis of the blood of participants in trials, are based on more extensive analysis than those released by the US drugmaker last week.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-covid-vaccine-pune-serum-institute-covaxin-covishield-astrazeneca-covid-vaccine-rollout-news-cases-mumbai-delhi-tamil-nadu-bengaluru-narendra-modi-940668.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>Last week, Pfizer said a similar laboratory study showed the vaccine was effective against one key mutation, called N501Y, found in both of the highly transmissible new variants spreading in Britain and South Africa.</p>.<p>The latest study, which has not yet been peer-reviewed, was conducted on 10 mutations, which are characteristic of the variant known as B117 identified in Britain.</p>
<p>The Covid-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.</p>.<p>The encouraging results, based on an analysis of the blood of participants in trials, are based on more extensive analysis than those released by the US drugmaker last week.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-covid-vaccine-pune-serum-institute-covaxin-covishield-astrazeneca-covid-vaccine-rollout-news-cases-mumbai-delhi-tamil-nadu-bengaluru-narendra-modi-940668.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>Last week, Pfizer said a similar laboratory study showed the vaccine was effective against one key mutation, called N501Y, found in both of the highly transmissible new variants spreading in Britain and South Africa.</p>.<p>The latest study, which has not yet been peer-reviewed, was conducted on 10 mutations, which are characteristic of the variant known as B117 identified in Britain.</p>